[at noodls] – 20 February 2014 Dr. Bradley J. Monk to Join Prima BioMed’s Clinical Advisory Board ENGLISH SYDNEY, AUSTRALIA – Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (Prima, the Company) announced … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
[Marketwired] – Prima BioMed Ltd announced today that Bradley J. Monk, MD, an esteemed clinical researcher and practicing gynecological oncologist, has joined Prima’s Clinical Advisory Board to advise the Company’s development … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
[at noodls] – 12 February 2014 Pete A. Meyers to Join Prima BioMed’s Board of Directors ENGLISH SYDNEY, AUSTRALIA – Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (Prima, the Company) is pleased to … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
[Marketwired] – Prima BioMed Ltd is pleased to announce that Pete A. Meyers will join Prima’s Board as a Non-Executive Director with immediate effect. moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
[at noodls] – Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) (Prima, the Company) today released its Appendix 4C – Quarterly Report for the three month period ending 31 March 2013. … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
[Other] – Prima BioMed Ltd today released its Appendix 4C – Quarterly Report for the three month period ending 31 March 2013. The Company had A$25.18 million in cash and term deposits as of the end of the quarter. … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is […]
[at noodls] – Prima BioMed Ltd (Prima or the Company) is pleased to provide the offer documentation relating to its recently announced share purchase plan (SPP), including a booklet … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
[at noodls] – Prima BioMed Ltd (Prima or the Company) is pleased to provide an update on its planned Share Purchase Plan (SPP). … This is an abstract of the original noodl. To continue … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to […]
[at noodls] – 3.8 million Euro grant to support CVac Development; Prima moving forward with pilot of CVac in additional cancer indications Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) (Prima, … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
[at noodls] – Ovarian Cancer About CVacâ„¢ Treatment Clinical Trials Announcements 04 February 2013 PRIMA BIOMED ANNOUNCES TWO ACCEPTED ABSTRACTS FOR PRESENTATION AT ISCT ANNUAL MEETING SYDNEY, AUSTRALIA – Prima BioMed … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
